Regencell Bioscience Holdings Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

6.20$ +0.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Income Statement RGC
Line item	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2022	2023	2024	2025
Revenue	0.38	0.46	0.44	16.31	52.39	12.17	62.92	0.49	0.48	17.35	0.48	0.51	0.50	0.53	0.54	0.53	0.00	0.00	0.00	0.00	–
Cost of Revenue	0.01	0.02	0.02	0.62	2.10	0.47	2.41	0.20	0.02	0.62	0.02	0.02	0.02	0.20	0.21	0.02	–	0.00	0.00	0.00	0.00
Gross Profit	0.37	0.44	0.42	15.69	50.29	11.70	60.51	0.30	0.46	16.73	0.46	0.49	0.48	0.32	0.33	0.51	–	0.00	0.00	0.00	0.00
Research & Development	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00	0.01	0.00	0.00	0.00
Selling, General & Administrative	0.01	0.01	0.01	0.40	1.31	0.29	1.41	0.08	0.01	0.43	0.01	0.01	0.01	0.08	0.09	0.01	0.00	0.01	0.01	0.01	0.00
Total Operating Expenses	0.33	0.39	0.38	14.57	46.16	10.70	56.47	0.24	0.21	6.74	0.18	0.20	0.20	0.27	0.27	0.22	0.00	0.02	0.01	0.01	0.01
Operating Income	0.05	0.07	0.06	1.74	6.21	1.47	6.45	0.05	0.04	1.43	0.06	0.06	0.05	0.06	0.06	0.05	0.00	-0.02	-0.01	-0.01	-0.01
Interest Expense	0.01	0.01	0.02	0.76	2.52	0.51	2.82	0.03	–	–	–	–	–	–	0.00	0.00	0.00	0.00	–	–	–
Pre-Tax Income	0.04	0.06	0.03	0.99	2.90	2.77	2.79	0.03	0.01	0.37	0.04	0.04	0.03	0.04	0.05	0.04	0.00	-0.02	-0.01	-0.01	-0.01
Income Tax Expense	0.02	0.02	0.01	0.39	1.15	1.11	1.14	0.01	0.01	0.11	0.02	0.02	0.01	0.02	0.02	0.02	0.00	0.00	0.00	0.00	–
Net Income	0.02	0.03	0.01	0.59	1.73	1.66	1.63	0.02	0.01	0.26	0.02	0.03	0.02	0.03	0.03	0.02	0.00	-0.02	-0.01	-0.01	-0.01
EBITDA	0.07	0.07	0.04	1.51	4.34	3.09	4.54	0.09	0.06	1.68	0.07	0.08	0.07	0.08	0.09	0.08	0.00	-0.01	-0.01	-0.01	-0.01

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?